CHICAGO, Jan. 28, 2026 (GLOBE NEWSWIRE) -- COUR Pharma, a clinical-stage biotechnology company developing first-in-class, antigen-specific immune tolerance therapies for autoimmune diseases, announced ...
Researchers developed a topical gene therapy that corrects disease-causing mutations in human skin models using lipid ...
Researchers have demonstrated that liposomes target tumours more effectively and reduce side effects, while others have observed that these nanomedicines improve the penetration and specificity of ...
News Medical on MSN
First topical CRISPR gene therapy corrects disease-causing mutations in human skin
Gene-editing tools like CRISPR have unlocked new treatments for previously uncurable diseases. Now, researchers at the ...
Some scientists who argue for deregulation deny outdoor gene editing is possible. But patents and the scientific literature ...
AZoLifeSciences on MSN
Expanding CRISPR to tackle incurable skin diseases
Gene-editing techniques such as CRISPR have enabled new treatments for previously incurable diseases. Researchers at the ...
Researchers have developed smart nanoparticles that can seek out and destroy disease-causing proteins the body can’t normally eliminate. Unlike traditional drugs, these particles can reach ...
Artificial intelligence has gotten a bad reputation lately, and often for good reason. But a team of scientists at Google’s ...
Every time a cell divides, it must copy its entire genome so that each daughter cell inherits a complete set of DNA. During ...
For almost 60 years, scientists have tried to understand why DNA doesn't replicate wildly and uncontrollably every time a ...
DeepMind’s AlphaGenome AI model could help solve the problem of predicting how variations in noncoding DNA shape gene expression ...
Viral DNA that is usually dismissed when sequencing the human genome could help to uncover useful information about complex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results